APC 2025 Agenda
Thursday April 10, 2025 |
||||
| Updated 2/04/2025 *Speakers and titles are subject to change | ||||
| Session | Speaker | Company | Time | |
| Registration and Coffee | 8:00AM-9:00AM | |||
| Conference Opening | David Ebner | Pfizer | 9:00AM-9:05AM | |
| Speaker Introduction | 9:05AM-9:10AM | |||
|
PROTAb Platform: An Innovative Universal Linker for DACs with CRBN-Based Degraders |
Teresa Mako | Orum | 9:10AM-9:40AM | |
| Speaker Introduction | 9:40AM-9:45AM | |||
| Drugging MYC mRNA with Small Molecules | Karthik Iyer | Arrakis Therapeutics | 9:45AM-10:15AM | |
| Speaker Introduction | 10:15AM-10:20AM | |||
| Title TBA | Scott Tria | ARTBIO | 10:20AM-10:50AM | |
| AM Break | 10:50AM-11:10AM | |||
| Speaker Introduction | 11:10AM-11:15AM | |||
| Title TBA | Martin Himmelbauer | Biogen | 11:15AM-11:45AM | |
| Speaker Introduction | 11:45AM-11:50AM | |||
| Title TBA | Kevin Filipski | Pfizer | 11:50AM-12:20PM | |
| Speaker Introduction | Andy Tsai | Treeline Biosciences | 12:20PM-12:25PM | |
|
Plenary Lecture Chemical Tools for Regulating Reactive Sulfur Species in Redox Biology |
Ming Xian | Brown University | 12:25AM-1:05PM | |
| Lunch | 1:05PM-2:20PM | |||
| Speaker Introduction | David Ebner | Pfizer | 2:20PM-2:25PM | |
| Vendor Talk - Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations | Adam Levinson |  |
2:25PM-2:50PM | |
| Speaker Introduction | 2:50PM-2:55PM | |||
| DNA Encoded Libraries – Drug Discovery through DEL screening and the Application of On-DNA Binder Confirmation | Mark Mantell | GSK | 2:55PM-3:25PM | |
| Speaker Introduction | 3:25PM-3:30PM | |||
| Discovery of a Novel Aryl Ether Small Molecule Inhibitor of the YAP1-TEAD Transcriptional Complex | Brandon Vara | Merck | 3:30PM-4:00PM | |
| PM Break | 4:00PM-4:15PM | |||
| Plenary Speaker Introduction | 4:15PM-4:20PM | |||
|
Plenary Lecture Chemical Biology Tools for Measuring Intracellular Drug Delivery |
Joshua Kritzer | Tufts University | 4:20PM-5:00PM | |
| Closing Remarks | Catherine Jorand-Lebrun | Nexo Therapeutics | 5:00PM-5:05PM | |
| Reception | 5:05PM-6:05PM | |||